These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 23280212)

  • 1. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events".
    Kountouras J; Papaefthymiou A; Liatsos C; Tzitiridou-Chatzopoulou M; Chatzopoulos D; Gialamprinou D; Kotronis G; Vardaka E; Kazakos E; Doulberis M
    Clin Nutr; 2022 Aug; 41(8):1855-1856. PubMed ID: 35780067
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Omega-3 and Omega-6 on Cardiovascular Risk Factors: Importance of Dietary Sources and Lipid Structure.
    Soares VM; Silva TCD; Santos PPD
    Arq Bras Cardiol; 2023 Nov; 120(11):e20230753. PubMed ID: 38126490
    [No Abstract]   [Full Text] [Related]  

  • 3. Omega-3 Fatty Acids: Not Really Fishy; Lessons Learned.
    Kremer JM
    Arthritis Rheumatol; 2024 Jun; 76(6):836-838. PubMed ID: 38268497
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply.
    MacFarlane LA; Lee IM; Katz JN; Manson JE; Costenbader KH
    Arthritis Rheumatol; 2021 May; 73(5):901-902. PubMed ID: 33452861
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary Supplements in Cardiovascular and Metabolic Diseases.
    Trimarco B; Santulli G
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifiable Risk Factors and Cardiovascular Outcomes. Reply.
    Magnussen C; Leong DP; Blankenberg S
    N Engl J Med; 2023 Dec; 389(25):2401-2402. PubMed ID: 38118041
    [No Abstract]   [Full Text] [Related]  

  • 7. PURLs: should you still recommend omega-3 supplements?
    Monaco J; Mounsey A; Bello Kottenstette J
    J Fam Pract; 2013 Aug; 62(8):422-4. PubMed ID: 24143335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids and cardiovascular risk.
    Kruse LG; Ogletree RL
    J Miss State Med Assoc; 2013 Jun; 54(6):156-7. PubMed ID: 23991511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].
    Casula M; Soranna D; Catapano AL; Corrao G
    Atheroscler Suppl; 2013 Aug; 14(2):243-51. PubMed ID: 23958480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary ω-3 polyunsaturated fatty acids are protective for myopia.
    Pan M; Zhao F; Xie B; Wu H; Zhang S; Ye C; Guan Z; Kang L; Zhang Y; Zhou X; Lei Y; Wang Q; Wang L; Yang F; Zhao C; Qu J; Zhou X
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34675076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy.
    Lee SM; Chung SH; Park Y; Park MK; Son YK; Kim SE; An WS
    Int J Endocrinol; 2015; 2015():208121. PubMed ID: 26089878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acid supplementation and cardiovascular disease events.
    Vlachopoulos C; Richter D; Stefanadis C
    JAMA; 2013 Jan; 309(1):28. PubMed ID: 23280210
    [No Abstract]   [Full Text] [Related]  

  • 13. Omega-3 fatty acid supplementation and cardiovascular disease events.
    Sethi A; Singh M; Arora R
    JAMA; 2013 Jan; 309(1):27-8. PubMed ID: 23280209
    [No Abstract]   [Full Text] [Related]  

  • 14. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.
    Cao Y; Lu L; Liang J; Liu M; Li X; Sun R; Zheng Y; Zhang P
    Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.
    Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):808-18. PubMed ID: 23110790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 fatty acid supplementation and cardiovascular disease events--reply.
    Rizos EC; Ntzani EE; Elisaf MS
    JAMA; 2013 Jan; 309(1):29. PubMed ID: 23280212
    [No Abstract]   [Full Text] [Related]  

  • 17. Omega-3 fatty acid supplementation and cardiovascular disease events.
    Galli C; Brenna JT
    JAMA; 2013 Jan; 309(1):28-9. PubMed ID: 23280211
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.